NEW YORK (GenomeWeb News) – AdvanDx recently announced the appointment of Alpha Laboratories to support the launch of AdvanDx's molecular QuickFISH test.

Under the terms of the deal, Alpha Lab has the exclusive rights to distribute the test in the UK. QuickFISH detects Staphylococcus aureus and/or coagulase-negative staphylococci and received 510(k) clearance from the US Food and Drug Administration in April. It was launched in the US and Europe in September.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: mtDNA analysis give glimpse into decline of Neanderthals in Europe, and more.

The University of Arizona's Raina Maier writes that an understanding of the Earth's microbiome is needed.

The proposed Canadian budget emphasizes partnerships with industry, Nature News reports.

An Australian study of personalized medicine has run into problems as it recruits patients.

Apr
29
Sponsored by
Covance

This online seminar will review case studies demonstrating the clinical utility of CTCs and cfDNA to define and characterize a variety of dynamic genomic changes throughout the course of cancer detection and treatment.